InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Net Income | 31.67% | 18.81% | 12.05% | 7.77% | 14.09% |
| Total Depreciation and Amortization | 33.63% | 0.41% | 9.73% | 36.06% | -37.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.09% | 23.75% | 67.17% | 138.11% | 1,691.17% |
| Change in Net Operating Assets | 47.97% | -11.86% | -38.01% | -42.29% | 127.35% |
| Cash from Operations | 81.79% | 72.59% | 55.48% | 49.93% | 70.12% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -80.57% | -71.89% | -71.89% | 120.57% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -111.90% | 27.92% | 81.74% | 92.14% | -80.05% |
| Cash from Investing | -109.59% | -7.96% | 83.00% | 96.15% | -76.84% |
| Total Debt Issued | -78.99% | -64.37% | -66.57% | -34.65% | 70.47% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.72% | 80.72% | -- | -- | -97.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -68.21% | -50.19% | -45.52% | -2.68% | -66.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.07% | 113.46% | 96.22% | 95.82% | -274.59% |